Recurrent Childhood Visual Pathway and Hypothalamic Glioma: Clinical Trials

17 trials for Recurrent Childhood Visual Pathway and Hypothalamic Glioma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

14 completed, 2 terminated, 1 withdrawn. 11 Phase 1, 4 Phase 2, 2 Not applicable.

By phase and status

PhaseTrialsStatus
Phase 111Completed 10, Terminated 1
Phase 24Completed 4
Not applicable2Terminated 1, Withdrawn 1

Follow Recurrent Childhood Visual Pathway and Hypothalamic Glioma: new trials by email Literature Review of Recurrent Childhood Visual Pathway and Hypothalamic Glioma trials Research Report on Recurrent Childhood Visual Pathway and Hypothalamic Glioma

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
18F-FDOPA PET/CT or PET/MRI in Measuring Tumors in Patients With Newly-Diagnosed or Recurrent Gliomas
18F-fluoro-dihydroxyphenylalanine, Positron emission tomography (PET), Computed tomography (CT) - Adult Anaplastic Ependymoma, Adult Anaplastic Oligodendroglioma
Not applicableTerminatedErik Mittra22014-12-012017-03-20
Efficacy of 68Ga-DOTATOC Positron Emission Tomography (PET) CT in Children and Young Adults With Brain Tumors
gallium Ga 68-edotreotide, positron emission tomography, computed tomography - Acoustic Schwannoma, Adult Anaplastic Astrocytoma
Not applicableWithdrawnSue O'Dorisio2013-09-012017-04-28
Gamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS Tumors, Lymphoma, or T-Cell Leukemia
gamma-secretase/Notch signalling pathway inhibitor RO4929097, diagnostic laboratory biomarker analysis, pharmacological study - Childhood Atypical Teratoid/Rhabdoid Tumor, Childhood Central Nervous System Choriocarcinoma
Phase 1TerminatedNational Cancer Institute (NCI)1292010-03-012014-11-05
Vorinostat and Temozolomide in Treating Young Patients With Relapsed or Refractory Primary Brain Tumors or Spinal Cord Tumors
vorinostat, temozolomide, diagnostic laboratory biomarker analysis - Childhood Atypical Teratoid/Rhabdoid Tumor, Childhood Central Nervous System Choriocarcinoma
Phase 1CompletedNational Cancer Institute (NCI)272010-02-012013-05-03
Vorinostat and Bortezomib in Treating Young Patients With Refractory or Recurrent Solid Tumors, Including Central Nervous System Tumors and Lymphoma
vorinostat, bortezomib, pharmacological study - Childhood Burkitt Lymphoma, Childhood Central Nervous System Choriocarcinoma
Phase 1CompletedNational Cancer Institute (NCI)202009-08-012013-07-02
ABT-888 and Temozolomide in Treating Young Patients With Recurrent or Refractory CNS Tumors
veliparib, temozolomide, pharmacological study - Childhood Atypical Teratoid/Rhabdoid Tumor, Childhood Central Nervous System Germ Cell Tumor
Phase 1CompletedNational Cancer Institute (NCI)312009-07-012014-07-09
Cilengitide in Treating Younger Patients With Recurrent or Progressive High-Grade Glioma That Has Not Responded to Standard Therapy
cilengitide, laboratory biomarker analysis, pharmacological study - Childhood High-grade Cerebellar Astrocytoma, Childhood High-grade Cerebral Astrocytoma
Phase 2CompletedNational Cancer Institute (NCI)302008-06-012018-08-01
Busulfan, Melphalan, Topotecan Hydrochloride, and a Stem Cell Transplant in Treating Patients With Newly Diagnosed or Relapsed Solid Tumor
busulfan, melphalan, topotecan hydrochloride - Solid Tumor, Adult Central Nervous System Germ Cell Tumor
Phase 1CompletedCity of Hope Medical Center252007-02-262025-03-20
Ispinesib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Lymphoma
ispinesib, laboratory biomarker analysis, pharmacological study - Childhood Burkitt Lymphoma, Childhood Central Nervous System Germ Cell Tumor
Phase 1CompletedNational Cancer Institute (NCI)302006-06-012013-01-16
Lenalidomide in Treating Young Patients With Recurrent, Progressive, or Refractory CNS Tumors
lenalidomide, perfusion-weighted magnetic resonance imaging, diffusion-weighted magnetic resonance imaging - Childhood Atypical Teratoid/Rhabdoid Tumor, Childhood Central Nervous System Germ Cell Tumor
Phase 1CompletedNational Cancer Institute (NCI)452004-11-012013-09-30
Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous Treatment
oxaliplatin - Childhood Central Nervous System Germ Cell Tumor, Childhood Extragonadal Germ Cell Tumor
Phase 2CompletedNational Cancer Institute (NCI)1802004-10-012013-06-05
Tipifarnib in Treating Young Patients With Recurrent or Progressive High-Grade Glioma, Medulloblastoma, Primitive Neuroectodermal Tumor, or Brain Stem Glioma
tipifarnib - Childhood High-grade Cerebral Astrocytoma, Childhood Oligodendroglioma
Phase 2CompletedNational Cancer Institute (NCI)902003-11-012013-10-08
Cilengitide in Treating Children With Refractory Primary Brain Tumors
cilengitide, laboratory biomarker analysis - Childhood Central Nervous System Germ Cell Tumor, Childhood Choroid Plexus Tumor
Phase 1CompletedNational Cancer Institute (NCI)242003-07-012013-09-30
Temozolomide and O6-Benzylguanine in Treating Children With Recurrent Brain Tumors
O6-benzylguanine, temozolomide, filgrastim - Childhood Central Nervous System Germ Cell Tumor, Childhood Choroid Plexus Tumor
Phase 1CompletedNational Cancer Institute (NCI)722002-10-012013-09-30
FR901228 in Treating Children With Refractory or Recurrent Solid Tumors or Leukemia
romidepsin - Blastic Phase Chronic Myelogenous Leukemia, Childhood Central Nervous System Germ Cell Tumor
Phase 1CompletedNational Cancer Institute (NCI)302002-09-012013-01-16
Flavopiridol in Treating Children With Relapsed or Refractory Solid Tumors or Lymphomas
alvocidib, pharmacological study - Recurrent Childhood Brain Stem Glioma, Recurrent Childhood Cerebellar Astrocytoma
Phase 1CompletedNational Cancer Institute (NCI)302001-04-012013-07-02
Irinotecan in Treating Children With Refractory Solid Tumors
irinotecan hydrochloride - Childhood Central Nervous System Germ Cell Tumor, Childhood Choroid Plexus Tumor
Phase 2CompletedChildren's Oncology Group1811999-10-012013-06-14

Narrower conditions

Astrocytoma (17)  ·  Optic Nerve Glioma (17)  ·  Familial ependymoma (14)  ·  Medulloblastoma (14)  ·  Oligodendroglioma (12)  ·  Choroid Plexus Neoplasms (11)  ·  Spinal Cord Neoplasms (5)  ·  Burkitt Lymphoma (4)  ·  Dendritic Cell Sarcoma, Interdigitating (4)  ·  Neuroblastoma (4)  ·  Neuroectodermal Tumors, Primitive, Peripheral (4)  ·  Rhabdoid Tumor (4)  ·  Brain Neoplasms (3)  ·  Osteosarcoma (3)  ·  Recurrence (3)

Broader conditions

Cranial Nerve Diseases (17)  ·  Cranial Nerve Neoplasms (17)  ·  Eye Diseases (17)  ·  Neoplasms (17)  ·  Neoplasms by Histologic Type (17)  ·  Neoplasms by Site (17)  ·  Neoplasms, Germ Cell and Embryonal (17)  ·  Neoplasms, Glandular and Epithelial (17)  ·  Neoplasms, Nerve Tissue (17)  ·  Nervous System Diseases (17)  ·  Nervous System Neoplasms (17)  ·  Neuroectodermal Tumors (17)  ·  Optic Nerve Diseases (17)  ·  Optic Nerve Neoplasms (17)  ·  Peripheral Nervous System Neoplasms (17)

Interventions

Temozolomide (3)  ·  2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole (2)  ·  Cilengitide (2)  ·  Filgrastim (2)  ·  Granulocyte Colony-Stimulating Factor (2)  ·  Magnetic Resonance Spectroscopy (2)  ·  Vorinostat (2)  ·  2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide (1)  ·  Bone Marrow Transplantation (1)  ·  Bortezomib (1)  ·  Busulfan (1)  ·  CK0238273 (1)  ·  Calcium Dobesilate (1)  ·  Dexamethasone (1)  ·  Irinotecan (1)

Sponsors

National Cancer Institute (NCI) (13)  ·  Children's Oncology Group (1)  ·  City of Hope Medical Center (1)  ·  Erik Mittra (1)  ·  Sue O'Dorisio (1)

Countries

United States (17)  ·  Canada (3)

Top investigators

Maryam Fouladi (2)  ·  Tobey MacDonald (2)  ·  Amar Gajjar (1)  ·  Anna Pawlowska, MD (1)  ·  Erik Mittra, MD, PhD (1)  ·  Jack Su (1)  ·  James Whitlock (1)  ·  Jodi Muscal (1)  ·  Katherine Warren (1)  ·  Lisa Bomgaars (1)  ·  M. Sue O'Dorisio, MD, PhD (1)  ·  Najat Daw (1)  ·  Orren Beaty (1)  ·  Richard Sills (1)  ·  Trent Hummel (1)

Results publications

PMID 23554030

NIH funding

U01CA097452 (6), U01CA081457 (4), U10CA098543 (4), P30CA086862 (1), P30CA124435 (1)